Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?

Biochimica et biophysica acta - 8 Aug 1997

Cox A D, Der C J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alkyl and Aryl Transferases
Share to Cell Line, Transformed
Share to Chemotherapy, Adjuvant
Share to Drug Design

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Farnesyltranstransferase

Share to Protein Prenylation

Share to ras Proteins

Share to Transferases

Source

Identifiers

PMID: 9294018
DOI: 10.1016/s0304-419x(97)00011-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Farnesyltransferase inhibitors and cancer treatment: targeting simply Ras?PMID 9294018Read ↗

Evolving therapies: farnesyltransferase inhibitors.Semantic proximity Read ↗

Ras farnesyltransferase: a new therapeutic target.Semantic proximity Read ↗

Ras protein farnesyltransferase: A strategic target for anticancer therapeutic development.Semantic proximity Read ↗

Farnesyltransferase inhibitors: potential role in the treatment of cancer.Semantic proximity Read ↗

Farnesyltransferase inhibitors versus Ras inhibitorsSemantic proximity Read ↗

Perspectives on farnesyl transferase inhibitors in cancer therapySemantic proximity Read ↗

Targeting the Ras signaling pathway: a rational, mechanism-based treatment for hematologic malignancies?Semantic proximity Read ↗

A RAS renaissance: emerging targeted therapies for KRAS-mutated non-small cell lung cancer.Semantic proximity Read ↗

Drugging RAS: Know the enemy.Semantic proximity Read ↗

Farnesyltransferase Inhibitor as Anticancer AgentSemantic proximity Read ↗

RAS: Target for Cancer TherapySemantic proximity Read ↗

Tailoring Ras-pathway--inhibitor combinations for cancer therapy.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.